Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes-Reference-Cited by-同舟云学术

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes

Published:2016-07 Issue:7 Volume:22 Page:1197-1205
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Flowers Christopher R.,Costa Luciano J.,Pasquini Marcelo C.,Le-Rademacher Jennifer,Lill Michael,Shore Tsiporah B.,Vaughan William,Craig Michael,Freytes Cesar O.,Shea Thomas C.,Horwitz Mitchell E.,Fay Joseph W.,Mineishi Shin,Rondelli Damiano,Mason James,Braunschweig Ira,Ai Weiyun,Yeh Rosa F.,Rodriguez Tulio E.,Flinn Ian,Comeau Terrance,Yeager Andrew M.,Pulsipher Michael A.,Bence-Bruckler Isabelle,Laneuville Pierre,Bierman Philip,Chen Andy I.,Kato Kazunobu,Wang Yanlin,Xu Cong,Smith Angela J.,Waller Edmund K.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference51 articles.

1. Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphoma;Bains;Leuk Lymphoma,2014

2. Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma;Josting;J Clin Oncol,2010

3. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial;Linch;Lancet,1993

4. Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation–a similar experience;Santos;Biol Blood Marrow Transplant,2007

5. Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center for International Blood & Marrow Transplant Research (CIBMTR);Lazarus;Biol Blood Marrow Transplant,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Toxicity and Efficacy of Four Different Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Patients With Lymphoma: Impact of Drug Shortages in a Resource-Constrained Country;Transplantation and Cellular Therapy;2024-08

2. Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas;International Journal of Hematology;2024-04-08

3. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients;Iraqi Journal of Hematology;2024-01

4. Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma;Cancers;2023-03-31

5. Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review;Frontiers in Immunology;2023-01-17